| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.TINS.2008.12.003 |
| P698 | PubMed publication ID | 19268374 |
| P50 | author | Sébastien S. Hébert | Q42384154 |
| P2093 | author name string | Bart De Strooper | |
| P2860 | cites work | Strategies for silencing human disease using RNA interference | Q28288535 |
| Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts | Q34767395 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| neurodegeneration | Q1755122 | ||
| P304 | page(s) | 199-206 | |
| P577 | publication date | 2009-03-04 | |
| P1433 | published in | Trends in Neurosciences | Q3538443 |
| P1476 | title | Alterations of the microRNA network cause neurodegenerative disease | |
| P478 | volume | 32 |
| Q64784262 | Q64784262 |
| Q98245634 | A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis |
| Q35106556 | A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients |
| Q33781096 | A map of human microRNA variation uncovers unexpectedly high levels of variability |
| Q35035504 | A new short oligonucleotide-based strategy for the precursor-specific regulation of microRNA processing by dicer |
| Q37122270 | A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. |
| Q37180715 | Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis |
| Q37221070 | Advances with microRNAs in Parkinson's disease research |
| Q39489520 | Ago1 and Ago2 differentially affect cell proliferation, motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells |
| Q21202833 | Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function |
| Q37688799 | Ampelopsin attenuates brain aging of D-gal-induced rats through miR-34a-mediated SIRT1/mTOR signal pathway. |
| Q34269266 | An activity-regulated microRNA, miR-188, controls dendritic plasticity and synaptic transmission by downregulating neuropilin-2. |
| Q38887384 | An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases |
| Q59791985 | Anabolic Androgenic Steroids: Searching New Molecular Biomarkers |
| Q39739174 | Analysis of gene expression changes in the rat hippocampus after deep brain stimulation of the anterior thalamic nucleus. |
| Q55378706 | Association of lectin-like oxidized low density lipoprotein receptor 1 (OLR1) polymorphisms with late-onset Alzheimer disease in Han Chinese. |
| Q37075660 | Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a. |
| Q28536644 | AutomiG, a biosensor to detect alterations in miRNA biogenesis and in small RNA silencing guided by perfect target complementarity |
| Q37673274 | Basic mechanisms of neurodegeneration: a critical update |
| Q37952382 | Biological pathways to adaptability--interactions between genome, epigenome, nervous system and environment for adaptive behavior |
| Q48985565 | Biomarkers and evolution in Alzheimer disease |
| Q90681433 | Candidate Genes and MiRNAs Linked to the Inverse Relationship Between Cancer and Alzheimer's Disease: Insights From Data Mining and Enrichment Analysis |
| Q38224066 | Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases |
| Q41958415 | Chronic intermittent ethanol exposure and its removal induce a different miRNA expression pattern in primary cortical neuronal cultures |
| Q34683670 | Chronological changes in microRNA expression in the developing human brain |
| Q37254246 | Circulating microRNA is a biomarker of pediatric Crohn disease. |
| Q38103194 | Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases |
| Q90726536 | Circulatory miR-98-5p levels are deregulated during diabetes and it inhibits proliferation and promotes apoptosis by targeting PPP1R15B in keratinocytes |
| Q30416926 | Cis-acting polymorphisms affect complex traits through modifications of microRNA regulation pathways |
| Q37567411 | Clinical applications of microRNAs |
| Q36898059 | Co-regulation of intragenic microRNA miR-153 and its host gene Ia-2 β: identification of miR-153 target genes with functions related to IA-2β in pancreas and brain |
| Q48215851 | Common and rare variants of microRNA genes in autism spectrum disorders |
| Q35887465 | Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD) |
| Q34272420 | Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. |
| Q34220566 | Context-dependent functions of specific microRNAs in neuronal development |
| Q35369767 | Converging evidence implicates the abnormal microRNA system in schizophrenia |
| Q35911210 | Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126. |
| Q38365159 | Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders |
| Q27028008 | Current understanding of the role of microRNAs in spinocerebellar ataxias |
| Q38041425 | Decoding the non-coding RNAs in Alzheimer's disease |
| Q92210407 | Decreased Level of Blood MicroRNA-133b in Men with Opioid Use Disorder on Methadone Maintenance Therapy |
| Q36739324 | Deep sequencing identifies circulating mouse miRNAs that are functionally implicated in manifestations of aging and responsive to calorie restriction |
| Q45928684 | Deletion of tumor necrosis factor-α ameliorates neurodegeneration in Sandhoff disease mice. |
| Q64987729 | Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag®. |
| Q41866229 | Determining Associations between Human Diseases and non-coding RNAs with Critical Roles in Network Control |
| Q28534050 | Developmental and activity-dependent miRNA expression profiling in primary hippocampal neuron cultures |
| Q40506172 | Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease |
| Q38864081 | Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance |
| Q39000862 | Down-regulation of miRNA-30a alleviates cerebral ischemic injury through enhancing beclin 1-mediated autophagy |
| Q47377421 | Downregulation of miR-199b promotes the acute spinal cord injury through IKKβ-NF-κB signaling pathway activating microglial cells |
| Q38978614 | Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model. |
| Q58714289 | Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases |
| Q47904843 | Engagement of circular RNA HECW2 in the nonautophagic role of ATG5 implicated in the endothelial-mesenchymal transition |
| Q28388059 | Epigenetic changes induced by air toxics: formaldehyde exposure alters miRNA expression profiles in human lung cells |
| Q49668183 | Epigenetic profiles in polyglutamine disorders |
| Q38708405 | Epigenetic regulation of early neural fate commitment |
| Q42777701 | Evaluation and control of miRNA-like off-target repression for RNA interference |
| Q36249445 | Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment |
| Q21129257 | Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? |
| Q35103825 | Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement |
| Q36361562 | Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death. |
| Q28592712 | Gene network and pathway analysis of mice with conditional ablation of Dicer in post-mitotic neurons |
| Q48112220 | Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration |
| Q38502875 | HOCTAR database: a unique resource for microRNA target prediction |
| Q26752932 | Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis |
| Q33913297 | High-performance quantification of mature microRNAs by real-time RT-PCR using deoxyuridine-incorporated oligonucleotides and hemi-nested primers |
| Q36761209 | Hsa-miR-590-5p Interaction with SMAD3 Transcript Supports Its Regulatory Effect on The TGFβ Signaling Pathway |
| Q33611301 | Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53 |
| Q64112575 | Human Brain Injury and miRNAs: An Experimental Study |
| Q42390300 | Hunting for the ultimate liquid cancer biopsy - let the TEP dance begin |
| Q39227299 | Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease |
| Q35194710 | Identification of endogenous reference genes for the analysis of microRNA expression in the hippocampus of the pilocarpine-induced model of mesial temporal lobe epilepsy |
| Q36151066 | Identification of microRNAs with Dysregulated Expression in Status Epilepticus Induced Epileptogenesis |
| Q36337576 | Identification of novel microRNA signatures linked to acquired aplastic anemia |
| Q38251133 | Identifying the role of microRNAs in spinal cord injury |
| Q34077547 | Impaired neurosteroid synthesis in multiple sclerosis. |
| Q42573232 | Impulsivity and comorbid traits: a multi-step approach for finding putative responsible microRNAs in the amygdala |
| Q28476525 | Influence of stochastic gene expression on the cell survival rheostat after traumatic brain injury |
| Q90194759 | Insights into the Role of MicroRNAs in the Onset and Development of Diabetic Neuropathy |
| Q27024584 | Insights on the functional interactions between miRNAs and copy number variations in the aging brain |
| Q41009946 | LRRK2 in Transcription and Translation Regulation: Relevance for Parkinson's Disease |
| Q36586376 | Long-term exposure to black carbon, cognition and single nucleotide polymorphisms in microRNA processing genes in older men. |
| Q55346192 | Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson's disease. |
| Q90806509 | Lycium barbarum polysaccharides alleviate hydrogen peroxide-induced injury by up-regulation of miR-4295 in human trabecular meshwork cells |
| Q42156626 | MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression. |
| Q38874732 | MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim. |
| Q27321168 | MiR-299-5p regulates apoptosis through autophagy in neurons and ameliorates cognitive capacity in APPswe/PS1dE9 mice |
| Q26825514 | MicroRNA (miRNA): sequence and stability, viroid-like properties, and disease association in the CNS |
| Q40597746 | MicroRNA Profiling from RSV-Infected Biofluids, Whole Blood, and Tissue Samples. |
| Q26749540 | MicroRNA Target Recognition: Insights from Transcriptome-Wide Non-Canonical Interactions |
| Q38510942 | MicroRNA as Biomarkers and Diagnostics. |
| Q34091173 | MicroRNA assassins: factors that regulate the disappearance of miRNAs. |
| Q47994615 | MicroRNA association with synucleinopathy conversion in rapid eye movement behavior disorder |
| Q24630375 | MicroRNA dysregulation in psychiatric disease |
| Q27305161 | MicroRNA dysregulation in the spinal cord following traumatic injury |
| Q51899002 | MicroRNA expression changes during zebrafish development induced by perfluorooctane sulfonate |
| Q47214829 | MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls. |
| Q37617954 | MicroRNA implications across neurodevelopment and neuropathology |
| Q33701433 | MicroRNA in Situ Hybridization in the Human Entorhinal and Transentorhinal Cortex |
| Q35033677 | MicroRNA in central nervous system trauma and degenerative disorders |
| Q36831790 | MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis |
| Q38635154 | MicroRNA machinery in Parkinson's disease: a platform for neurodegenerative diseases |
| Q36392115 | MicroRNA miR124 is required for the expression of homeostatic synaptic plasticity. |
| Q35644179 | MicroRNA networks direct neuronal development and plasticity. |
| Q40994304 | MicroRNA screening identifies a link between NOVA1 expression and a low level of IKAP in familial dysautonomia. |
| Q89866105 | MicroRNA sequencing of rat hippocampus and human biofluids identifies acute, chronic, focal and diffuse traumatic brain injuries |
| Q34324544 | MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease |
| Q36832687 | MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10) |
| Q36525872 | MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. |
| Q24318325 | MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease |
| Q39333849 | MicroRNA-34a inhibits human brain glioma cell growth by down-regulation of Notch1. |
| Q33778743 | MicroRNA-related cofilin abnormality in Alzheimer's disease |
| Q39719620 | MicroRNAs and Alzheimer's Disease Mouse Models: Current Insights and Future Research Avenues |
| Q37728116 | MicroRNAs and deregulated gene expression networks in neurodegeneration |
| Q38140046 | MicroRNAs and multiple sclerosis: from physiopathology toward therapy |
| Q36031159 | MicroRNAs and the Regulation of Tau Metabolism |
| Q33961392 | MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases |
| Q34101214 | MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration |
| Q38272668 | MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis |
| Q35053672 | MicroRNAs as potential clinical biomarkers: emerging approaches for their detection |
| Q35624533 | MicroRNAs in Human Diseases: From Autoimmune Diseases to Skin, Psychiatric and Neurodegenerative Diseases |
| Q28382954 | MicroRNAs in Neurotoxicity |
| Q36602107 | MicroRNAs in age-related diseases |
| Q37885268 | MicroRNAs in brain development and degeneration |
| Q39164361 | MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis. |
| Q34078032 | MicroRNAs: master regulators of ethanol abuse and toxicity? |
| Q33559391 | Micromanagement of Immune System: Role of miRNAs in Helminthic Infections |
| Q35635783 | Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration |
| Q88209980 | MoS2 quantum dots modified with a labeled molecular beacon as a ratiometric fluorescent gene probe for FRET based detection and imaging of microRNA |
| Q35235869 | Modes of Aβ toxicity in Alzheimer's disease |
| Q38836004 | Molecular and cellular pathophysiology of preclinical Alzheimer's disease |
| Q36386234 | Morphine and microRNA Activity: Is There a Relation with Addiction? |
| Q34309942 | Morphine regulates dopaminergic neuron differentiation via miR-133b |
| Q36695844 | Mutation in the 3'untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy |
| Q35874830 | NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells |
| Q35885239 | Neuro-Epigenetic Indications of Acute Stress Response in Humans: The Case of MicroRNA-29c |
| Q36638284 | Neurodegeneration the RNA way |
| Q33605734 | Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta |
| Q37977656 | Non-coding RNAs with essential roles in neurodegenerative disorders |
| Q42566308 | Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice |
| Q33868183 | Northern blotting analysis of microRNAs, their precursors and RNA interference triggers |
| Q38101984 | Novel findings in pain processing pathways: implications for miRNAs as future therapeutic targets |
| Q37201369 | Opposing actions of environmental enrichment and Alzheimer's disease on the expression of hippocampal microRNAs in mouse models |
| Q38619356 | PINK1 Deficiency Decreases Expression Levels of mir-326, mir-330, and mir-3099 during Brain Development and Neural Stem Cell Differentiation |
| Q35150392 | Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression |
| Q48102880 | Paraquat and MPTP alter microRNA expression profiles, and downregulated expression of miR-17-5p contributes to PQ-induced dopaminergic neurodegeneration. |
| Q34174676 | Pathophysiology of translational regulation by microRNAs in multiple sclerosis |
| Q39855856 | PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes |
| Q38037157 | Plasma biomarkers for Alzheimer's disease: much needed but tough to find |
| Q35237559 | Practical Aspects of microRNA Target Prediction |
| Q34110227 | Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process |
| Q36661728 | Proton radiation-induced miRNA signatures in mouse blood: characterization and comparison with 56Fe-ion and gamma radiation. |
| Q42957866 | Putative Role of MicroRNA-Regulated Pathways in Comorbid Neurological and Cardiovascular Disorders |
| Q26782020 | RNA-Binding Proteins in the Regulation of miRNA Activity: A Focus on Neuronal Functions |
| Q36661037 | Radiation-induced micro-RNA expression changes in peripheral blood cells of radiotherapy patients |
| Q38934600 | Recent Insights Into Molecular Mechanisms of Propofol-Induced Developmental Neurotoxicity: Implications for the Protective Strategies |
| Q34999535 | Recent advances in our understanding of neurodegeneration |
| Q39593306 | Reciprocal Regulation between Bifunctional miR-9/9(∗) and its Transcriptional Modulator Notch in Human Neural Stem Cell Self-Renewal and Differentiation. |
| Q35962195 | Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis |
| Q58700237 | Revealing post-transcriptional microRNA-mRNA regulations in Alzheimer's disease through ensemble graphs |
| Q38021940 | Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis |
| Q34087933 | SeqBuster, a bioinformatic tool for the processing and analysis of small RNAs datasets, reveals ubiquitous miRNA modifications in human embryonic cells. |
| Q37254850 | Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice |
| Q36068338 | Simultaneous Determination of Multiple microRNA Levels Utilizing Biotinylated Dideoxynucleotides and Mass Spectrometry |
| Q34575786 | Slowly Produced MicroRNAs Control Protein Levels |
| Q98735446 | Small RNA Deep Sequencing Identifies a Unique miRNA Signature Released in Serum Exosomes in a Mouse Model of Sjögren's Syndrome |
| Q35111407 | Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression |
| Q35259274 | Specific sequence determinants of miR-15/107 microRNA gene group targets |
| Q55261761 | Stress-associated changes in salivary microRNAs can be detected in response to the Trier Social Stress Test: An exploratory study. |
| Q36589571 | Studying micro RNA Function and Dysfunction in Alzheimer's Disease |
| Q36798899 | Studying microRNAs in the brain: technical lessons learned from the first ten years |
| Q48114104 | Swimming attenuates d-galactose-induced brain aging via suppressing miR-34a-mediated autophagy impairment and abnormal mitochondrial dynamics. |
| Q50440796 | Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations. |
| Q49104984 | Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-β. |
| Q38584755 | Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders. |
| Q40795590 | The Impact of MicroRNAs on Brain Aging and Neurodegeneration |
| Q29618068 | The MicroRNA Spectrum in 12 Body Fluids |
| Q38692787 | The Outflow Pathway: A Tissue With Morphological and Functional Unity. |
| Q35966911 | The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders |
| Q90523100 | The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer |
| Q92280511 | The Roles of miRNAs in Medulloblastoma: A Systematic Review |
| Q37820094 | The emerging role of microRNAs in multiple sclerosis |
| Q38527233 | The epigenetics of aging and neurodegeneration. |
| Q38713790 | The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells |
| Q26858788 | The involvement of microRNAs in neurodegenerative diseases |
| Q35786141 | The many faces of Dicer: the complexity of the mechanisms regulating Dicer gene expression and enzyme activities |
| Q24608620 | The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases |
| Q27015587 | The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease |
| Q38200138 | The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review |
| Q38992087 | The role of RNA metabolism in neurological diseases. |
| Q35161303 | The role of the precursor structure in the biogenesis of microRNA |
| Q33826132 | The unique expression and function of miR-424 in human placental trophoblasts |
| Q24626017 | Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder |
| Q36812411 | Tight junction modulation of the blood brain barrier: CNS delivery of small molecules |
| Q35063007 | Unraveling the characteristics of microRNA regulation in the developmental and aging process of the human brain |
| Q35103403 | Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR-743a |
| Q35129482 | Update on non-canonical microRNAs |
| Q51317119 | Vertically encoded tetragonal hydrogel microparticles for multiplexed detection of miRNAs associated with Alzheimer's disease. |
| Q54122835 | lncRNA MALAT1/miR-205-5p axis regulates MPP+-induced cell apoptosis in MN9D cells by directly targeting LRRK2. |
| Q37699192 | miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD. |
| Q33947283 | miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease |
| Q36316525 | miR-181 interacts with signaling adaptor molecule DENN/MADD and enhances TNF-induced cell death |
| Q64118310 | miR-181a/b downregulation exerts a protective action on mitochondrial disease models |
| Q48397272 | miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model |
| Q38820031 | miR-20a regulates expression of the iron exporter ferroportin in lung cancer |
| Q92539620 | miR-30b-3p Inhibits Proliferation and Invasion of Hepatocellular Carcinoma Cells via Suppressing PI3K/Akt Pathway |
| Q48600153 | miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. |
| Q64860049 | miR-34a/BCL-2 signaling axis contributes to apoptosis in MPP+ -induced SH-SY5Y cells |
| Q40104844 | miR-525-5p inhibits ADAMTS13 and is correlated with Ischemia/reperfusion injury-induced neuronal cell death |
| Q38978854 | miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT. |
| Q35475193 | miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132 |
| Q89761067 | miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer's Disease |
| Q38088011 | miRNAs and long noncoding RNAs as biomarkers in human diseases |
| Q38623016 | miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease. |
| Q39104808 | miRNAs as biomarkers of neurodegenerative disorders |
| Q37535111 | miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy |
| Q34456543 | miRandola: extracellular circulating microRNAs database |
| Q42384091 | microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer's disease triple transgenic mice |
| Q64064849 | microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer |
| Q37424316 | microRNAs and genetic diseases |
| Q55231712 | microRNAs in Neurodegeneration: Current Findings and Potential Impacts. |
Search more.